The present study was conducted to examine alterations in the concentrations of plasma free amino acids, glucose, insulin, free fatty acids (FFAs), and urea nitrogen induced by branched-chain amino acid (BCAA) supplementation in young men. Overnightfasted subjects ingested drinks containing 1 or 5 g of a BCAA mixture (weight ratio of 1 : 2.3 : 1.2 for isoleucine : leucine : valine), and blood was intermittently collected for 3 h after ingestion. Ingestion of the BCAA mixture resulted in significant increases in the plasma concentrations of individual BCAAs, corresponding to the amounts of amino acids ingested. On the other hand, plasma concentrations of methionine and aromatic amino acids tended to decrease in the trial with 5 g BCAAs, suggesting that BCAA ingestion affects the metabolism of these amino acids. The ingestion of BCAAs temporarily increased plasma insulin levels and affected plasma concentrations of FFAs, but had almost no effect on glucose or urea nitrogen.
Branched-chain amino acids (BCAAs), leucine, isoleucine, and valine, comprise ~35% of the total content of essential amino acids in muscle proteins and almost 50% of the essential amino acids in foods ( 1 ) . It has been demonstrated that BCAAs, especially leucine, are physiologically important as regulators of protein metabolism ( 2 ) . Furthermore, recent studies suggested that BCAAs may also be involved in the regulation of glucose metabolism ( 3 , 4 ) .
In recent years, on account of their physiological effects, BCAAs have been widely used as nutritional supplements in sports and medication for patients with liver cirrhosis ( 5 ) . However, despite the common use of BCAAs, information with regard to the effects of BCAA intake on the concentrations of plasma components, including free amino acids other than the BCAAs, is limited. In a recent study, we found that BCAA supplementation before exercise induces decreases in plasma methionine and aromatic amino acid concentrations in young women ( 6 ) . Because it is known that the BCAA catabolism has gender differences ( 7 , 8 ) , in the present study we examined the BCAA supplementationinduced alterations in the concentrations of plasma components in young men.
Materials and Methods
Subjects. Five healthy male students were recruited as subjects from the Nagoya Institute of Technology (Nagoya, Japan). They were undergraduate or graduate students aged 22-25 y, and their mean height ( Ϯ SE), body weight and percent body fat were 176 Ϯ 2 cm, 61 Ϯ 3 kg, and 13.2 Ϯ 0.9%, respectively. Body fat was measured with a TBF-501 body composition analyzer (Tanita, Tokyo). The health condition of the subjects was examined by interview and blood testing before the experiments, to confirm that they did not have liver failure or diabetes. Participants were instructed to keep their regular dietary habits and to refrain from vigorous physical activity on the day before the experiment. The study design, purpose, and possible risks were explained to each subject before written consent was obtained. The study protocol was approved by the Human Research Review Committee of the Nagoya University School of Medicine.
BCAA drink. Test drinks were prepared by dissolving 1 or 5 g of a BCAA mixture (weight ratio of 1 : 2.3 : 1.2 for isoleucine : leucine : valine) and 1.2 g of non-nutritive sweetener (Pal Sweet, Ajinomoto Co., Inc., Tokyo) in 200 mL of distilled water. The three individual BCAAs were obtained from Ajinomoto, and the ratio of the BCAA mixture used was based on an amino acid composition shown in the 1985 report of a joint FAO/ WHO/UNU Expert Consultation (WHO Technical Report Series, No. 724) ( 9 ) .
Experimental design. On the day of the first experiment (ingestion of 1 g BCAA), overnight-fasted subjects reported to the laboratory at 0830 h, when the first blood collection (~3 mL) was carried out. The drink containing 1 g of the BCAA mixture was ingested at 0900 h, and blood samples (~3 mL) were collected 15, 30, 45, 60, 90, 120, and 180 min after ingestion. Plasma was prepared from the collected blood samples. The second experiment was conducted 5 d after the first one using the same procedures, except that the test drink contained 5 g of the BCAA mixture.
Analyses of blood components. An aliquot of the plasma samples was deproteinized as described previously ( 6 ) , and concentrations of free amino acids were determined using the automated JLC-500/V Amino Acid Analyzer (JEOL, Tokyo). The amino acid analyses were conducted in AminoScience Laboratories, Ajinomoto Co., Inc. (Kawasaki). Analyses of plasma glucose, insulin, free fatty acids (FFA), and urea nitrogen concentrations were conducted by the SRL Inc. (Tokyo).
Statistics. Data are expressed as means Ϯ SE. Changes over time within each trial were tested using 1-way repeated measures ANOVA. Statistical analyses were performed using StatView 5.0 (SAS Institute, Cary, NC) and Stat Mate III 3.14 (ATMS, Co., Ltd., Tokyo) software. p Ͻ 0.05 was considered statistically significant.
Results and Discussion
Alterations in plasma concentrations of individual BCAAs are shown in Fig. 1 . In response to the ingestion of 1 g of the BCAA mixture, the concentration of isoleucine in the plasma increased, reached a peak 15 min after ingestion, and then gradually decreased to the original level by 60 min after ingestion; the peak concentration was 66% higher than the original level. On the other hand, the trial with 5 g BCAA showed a peak 30 min after ingestion, reaching a concentration 320% higher than the basal level; after the peak, the concentration of isoleucine in the plasma gradually decreased to the initial level by 180 min after ingestion. Alterations in plasma concentrations of the other two BCAAs, leucine and valine, were similar to those of isoleucine in both trials. Since the leucine content in the BCAA mixture ingested was approximately twice that of the other BCAA contents, the increase rate of the plasma leucine concentration was higher than those of other plasma BCAAs; in comparison with basal levels, the concentrations of leucine and valine were increased 79% and 30% in the 1 g BCAA trial and 384% and 148% in the 5 g BCAA trial, respectively. These results indicate that approximately 5-fold higher increases in the concentrations of individual BCAAs after ingestion of 5 g BCAAs corresponded well with the amount of amino acid ingested. Table 1 shows the changes in the plasma concentrations of amino acids other than the BCAAs in response to ingestion of the BCAA mixture. While none of the free amino acids showed significant changes after inges-tion of 1 g BCAA, significant decreases in the concentrations of arginine, methionine, and three aromatic amino acids (phenylalanine, tryptophan, and tyrosine) were observed in the trial with 5 g BCAA; the concentrations of these amino acids decreased most during the 45-180 min post-ingestion period. In our previous study using young women, similar results were obtained: ingestion of 0.1 g BCAA per kg body weight before a ~23 min session of relatively low intensity squat exercise caused plasma concentrations of methionine and aromatic amino acids to decrease during the 1-2 h post-exercise period. These findings suggest that, although the catabolism of BCAA itself has gender differences ( 7 , 8 ) , ingestion of BCAAs may affect the metabolism of methionine and aromatic amino acids regardless of gender.
As we discussed previously ( 6 ), BCAA intake-induced up-regulation of the hepatic branched-chain ␣ -keto acid dehydrogenase complex (BCKDC), the rate-limiting enzyme in the BCAA catabolic pathway, may be involved in the mechanism which accounts for the decrease in plasma methionine concentration, because the catalytic activity of BCKDC affects the catabolism of methionine ( 1 , 10 ) and leucine ingestion activates hepatic BCKDC ( 11 ) . It is tempting to consider that the BCAA effect of lowering plasma aromatic amino acid concentrations observed in this and our previous study ( 6 ) may be related to the beneficial effect of BCAAs 130Ϯ8  128Ϯ9  132Ϯ10 133Ϯ10 131Ϯ9  NS  5  127Ϯ7  128Ϯ7  132Ϯ7  115Ϯ5  120Ϯ8  110Ϯ6  112Ϯ6  113Ϯ7  NS  Thr  1  150Ϯ8  157Ϯ8  157Ϯ6  148Ϯ6  144Ϯ7  146Ϯ7  149Ϯ7  149Ϯ7  NS  5  140Ϯ8  140Ϯ9  146Ϯ7  128Ϯ5  131Ϯ9  121Ϯ7  121Ϯ7  124Ϯ7  NS  Trp  1  50Ϯ4  54Ϯ4  52Ϯ4  48Ϯ3  48Ϯ4  46Ϯ4  44Ϯ3  42Ϯ3  NS  5  5 3 Ϯ5  53Ϯ5  53Ϯ4  46Ϯ2  45Ϯ2  41Ϯ3  39Ϯ3  39Ϯ2  Ͻ0.05  Tyr  1  60Ϯ5  64Ϯ5  63Ϯ4  55Ϯ4  54Ϯ4  51Ϯ5  52Ϯ5  50Ϯ6  NS  5  6 2 Ϯ6  61Ϯ7  61Ϯ5  50Ϯ5  50Ϯ5  42Ϯ5  36Ϯ5  37Ϯ4 Ͻ0.05
Data are presented as the meanϮSE. 1 p values were calculated for changes over time within each BCAA ingestion trial using 1-way ANOVA. 2 NS stands for non-significant. against hepatic encephalopathy, because decreases in the ratio of BCAAs to aromatic amino acids may play a causal role in hepatic encephalopathy by increasing the uptake of aromatic amino acids into the brain (12, 13) .
Although the mechanisms responsible for the BCAA effects on the plasma aromatic amino acid levels is currently unclear, the BCAAs might regulate the uptake of aromatic amino acids from the circulation to body tissues accounting for the large percentage of the whole body, such as skeletal muscles. Obviously, further studies are required to clarify this hypothesis. Plasma concentrations of glucose, insulin, FFA, and urea nitrogen are shown in Table 2 . Although the concentrations of these plasma components were significantly changed over time in both 1 and 5 g BCAA trials, glucose and urea nitrogen showed minor alterations, suggesting that ingestion of these amounts of BCAAs may not affect glucose utilization of the body tissues or urea production in the liver. Plasma insulin concentration was temporarily increased, with a peak 15 min post-ingestion in both trials. These increases in the plasma insulin levels may be attributed to the effect of leucine, which is known to promote insulin secretion (14) . However, the peaks of insulin and leucine did not coincide in the trial with 5 g BCAA (15 and 30 min, respectively), suggesting that leucine stimulates insulin secretion only during the early period after ingestion. Plasma FFA concentrations were decreased after ingestion of BCAA, and then gradually increased, reaching levels higher than before BCAA ingestion at 180 min in both 1 and 5 g BCAA trials. These decreases in FFAs may be caused by temporarily increased plasma insulin.
In conclusion, the present study showed that peak levels of individual BCAAs in the plasma correspond with the amounts of BCAA ingested and that ingestion of 5 g BCAA affects plasma concentrations of methionine and aromatic amino acids in young men. These results suggest that increases in the plasma levels of BCAAs, especially leucine, may promote the catabolism of methionine and aromatic amino acids. The ingestion of BCAA temporarily increased plasma insulin concentrations and affected plasma FFA, but almost no glucose or urea nitrogen, concentrations.
